Melinda Lantz

1.4k total citations
34 papers, 930 citations indexed

About

Melinda Lantz is a scholar working on Psychiatry and Mental health, Clinical Psychology and Physiology. According to data from OpenAlex, Melinda Lantz has authored 34 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 7 papers in Physiology. Recurrent topics in Melinda Lantz's work include Dementia and Cognitive Impairment Research (10 papers), Alzheimer's disease research and treatments (7 papers) and Geriatric Care and Nursing Homes (6 papers). Melinda Lantz is often cited by papers focused on Dementia and Cognitive Impairment Research (10 papers), Alzheimer's disease research and treatments (7 papers) and Geriatric Care and Nursing Homes (6 papers). Melinda Lantz collaborates with scholars based in United States, Israel and Japan. Melinda Lantz's co-authors include Deborah B. Marin, V Giambanco, Richard C. Mohs, Kenneth L. Davis, Dushyant P. Purohit, Daniel P. Perl, V. Haroutunian, Karim Khan, John Carter and Eileen R. Chichin and has published in prestigious journals such as American Journal of Psychiatry, Journal of the American Geriatrics Society and Atherosclerosis.

In The Last Decade

Melinda Lantz

31 papers receiving 870 citations

Peers

Melinda Lantz
Jo Ann T. Tschanz United States
Doris Svetlik United States
V Chandra United States
Ruth A. Mulnard United States
Judith Neugroschl United States
Byoung Hoon Oh South Korea
Jo Ann T. Tschanz United States
Melinda Lantz
Citations per year, relative to Melinda Lantz Melinda Lantz (= 1×) peers Jo Ann T. Tschanz

Countries citing papers authored by Melinda Lantz

Since Specialization
Citations

This map shows the geographic impact of Melinda Lantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda Lantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda Lantz more than expected).

Fields of papers citing papers by Melinda Lantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda Lantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda Lantz. The network helps show where Melinda Lantz may publish in the future.

Co-authorship network of co-authors of Melinda Lantz

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda Lantz. A scholar is included among the top collaborators of Melinda Lantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda Lantz. Melinda Lantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Lisa J., et al.. (2024). Long-Acting Injectable Antipsychotics in the Geriatric Population: A longitudinal Study. American Journal of Geriatric Psychiatry. 32(12). 1420–1430. 2 indexed citations
2.
Cummings, Natalie D., et al.. (2023). Infusing the "Motivation" into Motivational Interviewing: Addressing Unique Challenges in Older Adults with Substance Use Disorders. American Journal of Geriatric Psychiatry. 31(3). S70–S71.
3.
Lantz, Melinda, et al.. (2021). The Withdrawal After the Withdrawal: Managing Benzodiazepine Reduction and Post-Acute Withdrawal in Older Adults. American Journal of Geriatric Psychiatry. 29(4). S100–S101.
4.
Lantz, Melinda, et al.. (2020). “IT'S NOT ME, IT'S YOU” PERSONALITY DISORDERS IN GERIATRIC PATIENTS. American Journal of Geriatric Psychiatry. 28(4). S112–S113.
5.
Lantz, Melinda, et al.. (2018). From Stress to Serenity: The Use of Aromatherapy to Engage Patients in Care. American Journal of Geriatric Psychiatry. 26(3). S119–S119. 1 indexed citations
6.
Steiner, Victoria, et al.. (2008). Medication-related cognitive impairments in the elderly. 16(8). 11–14. 1 indexed citations
7.
Kennedy, Gary J., et al.. (2006). Training professional home care staff to help reduce depression in elderly home care recipients. 14(7). 13–16. 2 indexed citations
8.
Morrison, R. Sean, Eileen R. Chichin, John Carter, et al.. (2005). The Effect of a Social Work Intervention to Enhance Advance Care Planning Documentation in the Nursing Home. Journal of the American Geriatrics Society. 53(2). 290–294. 157 indexed citations
9.
Samuels, Steven C., et al.. (2002). The prevalence, diagnosis and treatment of depression in dementia patients in chronic care facilities in the last six months of life. International Journal of Geriatric Psychiatry. 17(5). 464–472. 44 indexed citations
10.
Lantz, Melinda, et al.. (2001). Pseudodementia. Cognitive decline caused by untreated depression may be reversed with treatment.. PubMed. 56(10). 42–3. 6 indexed citations
11.
Silverman, Jeremy M., Christopher M. Smith, Deborah B. Marin, et al.. (2000). Has familial aggregation in Alzheimer's disease been overestimated?. International Journal of Geriatric Psychiatry. 15(7). 631–637. 6 indexed citations
12.
Haroutunian, Vahram, Michael Serby, Dushyant P. Purohit, et al.. (2000). Contribution of Lewy Body Inclusions to Dementia in Patients With and Without Alzheimer Disease Neuropathological Conditions. Archives of Neurology. 57(8). 1145–1145. 57 indexed citations
13.
Haroutunian, V., Dushyant P. Purohit, Daniel P. Perl, et al.. (1999). Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease. Archives of Neurology. 56(6). 713–713. 175 indexed citations
14.
Davis, Kenneth L., Richard C. Mohs, Deborah B. Marin, et al.. (1999). Neuropeptide Abnormalities in Patients With Early Alzheimer Disease. Archives of General Psychiatry. 56(11). 981–981. 64 indexed citations
15.
Lantz, Melinda, et al.. (1999). St. John's Wort and Antidepressant Drug Interactions in the Elderly. Journal of Geriatric Psychiatry and Neurology. 12(1). 7–10. 128 indexed citations
16.
Gabriel, Steven M., Deborah B. Marin, Paul Aisen, et al.. (1998). Association of Elevated α1-Antichymotrypsin With Cognitive Impairment in a Prospective Study of the Very Old. American Journal of Psychiatry. 155(5). 698–700. 16 indexed citations
17.
Marin, Deborah B., Brenda Breuer, Michael L. Marin, et al.. (1998). The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. 140(1). 173–180. 46 indexed citations
18.
Li, Guangfu, Jeremy M. Silverman, Vahram Haroutunian, et al.. (1997). The Validity of the Family History Method for Identifying Alzheimer Disease. Archives of Neurology. 54(5). 634–640. 37 indexed citations
19.
Lantz, Melinda, et al.. (1996). A ten-year review of the effect of OBRA-87 on psychotropic prescribing practices in an academic nursing home. Psychiatric Services. 47(9). 951–955. 38 indexed citations
20.
Li, Ge, Jeremy M. Silverman, Larry D. Altstiel, et al.. (1996). Apolipoprotein E-η4 allele and familial risk in Alzheimer's disease. Genetic Epidemiology. 13(3). 285–298. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026